Clinical and economic consequences of medication nonadherence: a review of systematic reviews
Frontiers in Pharmacology · 25.06.2025 · 16
DOI: 10.3389/fphar.2025.1570359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.06.2025. Verfasst von Maria Achterbosch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Medication efficacy observed in clinical trials may differ from its effectiveness during real-world usage. Medication nonadherence is one of the key factors being responsible for this efficacy-effectiveness gap. The World Health Organization estimated that only 50% of chronic medication users is adherent and nonadherence results in both negative health outcomes for the patient and higher societal costs. An overview of the consequences across disease groups may allow some comparison and could contribute to identification of priority clinical areas.
Objective
We aimed to provide an overview the impact of nonadherence on clinical and economic outcomes.
Method
We narratively reviewed systematic reviews published between 2014 and 2024 on the effect of medication nonadherence on clinical and economic outcomes.
Results
Overall, 43 systematic reviews were identified, including over 410 original studies on clinical outcomes and 174 on economic outcomes, covering different clinical areas (e.g., organ transplantation, cardiovascular diseases, diabetes, depression and chronic lung diseases [asthma/COPD]). Beyond diminished treatment effects, medication nonadherence has been associated with elevated mortality, increased healthcare utilization (including hospital admissions), and higher direct (e.g., more healthcare provider visits) and indirect financial cost burden (e.g., work productivity losses due to absenteeism and presenteeism) for patients and society.
Conclusion
Medication nonadherence is associated with poor clinical and economic outcomes across disease areas. Given the significant impact of nonadherence, raising awareness among healthcare professionals and policymakers, early stakeholder engagement in intervention design, and eventually implementation of cost-effective interventions on both health policy, system and individual patient level are urgently required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
- Department of Clinical Pharmacy, School of Pharmacy, Altinbas University, Istanbul, Türkiye.
- Syreon Research Institute, Budapest, Hungary.
- Syreon Research Africa, Accra, Ghana.
- Medication Adherence Research Group, Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary.
- Department of Clinical Pharmacy & Pharmacology, Medication Adherence Expertise Center of the Northern Netherlands (MAECON), University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Zitieren
APA
Achterbosch, M., Aksoy, N., Obeng, G. D., Ameyaw, D., Ágh, T., & van Boven, J. F. M. (2025). Clinical and economic consequences of medication nonadherence: a review of systematic reviews. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1570359
Vancouver
Achterbosch M, Aksoy N, Obeng GD, Ameyaw D, Ágh T, van Boven JFM. Clinical and economic consequences of medication nonadherence: a review of systematic reviews. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1570359
BibTeX
@article{Achterbosch2025,
author = {Achterbosch, Maria and Aksoy, Nilay and Obeng, George D and Ameyaw, David and Ágh, Tamás and van Boven, Job F M},
title = {Clinical and economic consequences of medication nonadherence: a review of systematic reviews},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1570359}
}
EUVIMED